Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Alexion
Alexion
AZ's Alexion inks $125M deal to resolve investor lawsuit over Soliris sales tactics
AZ's Alexion inks $125M deal to resolve investor lawsuit over Soliris sales tactics
Fierce Pharma
Alexion
AstraZeneca
Soliris
investors
legal
Flag link:
EHA 2023 – Astrazeneca keeps up its complement defense
EHA 2023 – Astrazeneca keeps up its complement defense
EP Vantage
EHA
AstraZeneca
Alexion
Soliris
Ultomiris
Novartis
iptacopan
PNH
Flag link:
AstraZeneca's Alexion hopes to extend dominance in PNH as Big Pharma competitors close in
AstraZeneca's Alexion hopes to extend dominance in PNH as Big Pharma competitors close in
Fierce Biotech
AstraZeneca
Alexion
PNH
Ultomiris
Soliris
Roche
Apellis
Novartis
Flag link:
AstraZeneca pays 666% premium to buy genomic medicine biotech
AstraZeneca pays 666% premium to buy genomic medicine biotech
Fierce Biotech
AstraZeneca
M&A
Alexion
LogicBio Therapeutics
genomic medicine
Flag link:
AstraZeneca's Alexion bet continues to pay off as danicopan improves hemoglobin levels in phase 3
AstraZeneca's Alexion bet continues to pay off as danicopan improves hemoglobin levels in phase 3
Fierce Biotech
AstraZeneca
Alexion
danicopan
paroxysmal nocturnal hemoglobinuria
Flag link:
Data backs AZ’s Wilson disease drug, but with a question mark
Data backs AZ’s Wilson disease drug, but with a question mark
Pharmaforum
AstraZeneca
Wilson disease
Alexion
ALXN1840
Flag link:
AstraZeneca's Alexion, Arvinas nab space at future 10-story biotech tower in New Haven
AstraZeneca's Alexion, Arvinas nab space at future 10-story biotech tower in New Haven
Fierce Biotech
AstraZeneca
Alexion
Arvinas
Connecticut
Flag link:
AstraZeneca and Neurimmune close agreement to develop monoclonal antibody, NI006
AstraZeneca and Neurimmune close agreement to develop monoclonal antibody, NI006
Biopharma Reporter
Alexion
AstraZeneca
Neurimmune
N!006
monoclonal antibodies
transthyretin amyloid cardiomyopathy
Flag link:
Roche and AstraZeneca settle years long patent battle over Ultomiris — report
Roche and AstraZeneca settle years long patent battle over Ultomiris — report
Endpoints
Roche
Chugai
AstraZeneca
Alexion
patents
Ultomiris
Soliris
Flag link:
AstraZeneca and Neurimmune to develop investigational human monoclonal antibody NI006
AstraZeneca and Neurimmune to develop investigational human monoclonal antibody NI006
Biopharma Reporter
Alexion
AstraZeneca
Neurimmune
NI006
ATTR-CM
Flag link:
AstraZeneca blocks investor group's $7.6B buyout of rare disease specialist Sobi: report
AstraZeneca blocks investor group's $7.6B buyout of rare disease specialist Sobi: report
Fierce Pharma
AstraZeneca
Alexion
Sobi
M&A
Flag link:
AstraZeneca’s Alexion concludes Caelum acquisition for $500m
AstraZeneca’s Alexion concludes Caelum acquisition for $500m
Pharmaceutical Business Review
AstraZeneca
Alexion
Caelum Biosciences
M&A
Flag link:
AstraZeneca lays out $360M for 'next-gen' manufacturing plant in Dublin
AstraZeneca lays out $360M for 'next-gen' manufacturing plant in Dublin
Fierce Pharma
AstraZeneca
Alexion
Ireland
drug manufacturing
Flag link:
After Ultomiris stumble, Alexion delivers a rare disease win for AZ
After Ultomiris stumble, Alexion delivers a rare disease win for AZ
Pharmaforum
AstraZeneca
Alexion
ALXN1840
Wilson disease
Flag link:
AstraZeneca's newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says
AstraZeneca's newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says
Fierce Pharma
AstraZeneca
Soliris
Alexion
drug pricing
myasthenia gravis
Flag link:
AstraZeneca heralds new chapter as Alexion acquisition completed
AstraZeneca heralds new chapter as Alexion acquisition completed
Biopharma Reporter
AstraZeneca
Alexion
M&A
Flag link:
Biopharma throws grease on the deal wheels
Biopharma throws grease on the deal wheels
EP Vantage
M&A
Alexion
Achillion
Eli Lilly
Prevail Therapeutics
Flag link:
Alexion's new blockbuster Ultomiris keeps gaining steam as $39B AstraZeneca deal looms
Alexion's new blockbuster Ultomiris keeps gaining steam as $39B AstraZeneca deal looms
Fierce Pharma
AstraZeneca
Alexion
Ultomiris
Flag link:
Moderna's Joining the S&P 500: What's Next for the Hot Vaccine Stock?
Moderna's Joining the S&P 500: What's Next for the Hot Vaccine Stock?
Motley Fool
Moderna Therapeutics
Alexion
S&P 500
vaccines
COVID-19
Flag link:
Alexion touts new PhIII data of Soliris successor as planned AstraZeneca takeover looms
Alexion touts new PhIII data of Soliris successor as planned AstraZeneca takeover looms
Endpoints
Alexion
AstraZeneca
M&A
clinical trials
Ultomiris
myasthenia gravis
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »